Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for MS White Matter Lesions
NCT04025554Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Oct 2019
- Primary completion
- Oct 2023
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in multiple sclerosis (MS), sponsored by National Institute of Neurological Disorders and Stroke. Started Oct 2019; status: completed.
02
Drugs
anakinra
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04025554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04025554.